Fragment Growing to Design Optimized Inhibitors for Human Blood Group B Galactosyltransferase (GTB)

Human blood group B galactosyltransferase (GTB) catalyzes the galactosylation of the H antigen and is responsible for the formation of the blood group antigen of phenotype B. The ABO blood group system is well studied and routinely serotyped before transfusion and transplantation. Blood type subgroups have been repeatedly linked to an increased occurrence of diseases (e.g., a highly increased incidence rate for pancreatic cancer for individuals with blood group phenotype B). 3‐Phenyl‐5‐(piperazin‐1‐yl)‐1,2,4‐thiadiazole 1 has previously been described to inhibit GTB with a Ki value of 800 μm. In this work, we describe a computer‐guided fragment‐growing approach for the optimization of this fragment that was subsequently realized by synthesizing the most promising ligands. Enlarging the phenyl moiety of fragment 1 to a naphthyl moiety resulted in ligand 3‐(naphthalene‐1‐yl)‐5‐(piperazin‐1‐yl)‐1,2,4‐thiadiazole 2 a, which shows a threefold improvement in binding affinity (Ki=271 μm).

[1]  Guo-qing Wang,et al.  ABO blood type correlates with survival in hepatocellular carcinoma following hepatectomy , 2017, Scientific Reports.

[2]  S. Schnell,et al.  Closed Form Solution for Time-dependent Enzyme Kinetics , 1997 .

[3]  S. Hakomori.  Antigen structure and genetic basis of histo-blood groups A, B and O: their changes associated with human cancer. , 1999, Biochimica et biophysica acta.

[4]  R. Ellsworth,et al.  The role of the histoblood ABO group in cancer , 2016, Future science OA.

[5]  P. Greenwell.  Blood group antigens: molecules seeking a function? , 1997, Glycoconjugate Journal.

[6]  M. Palcic,et al.  Protein NMR Studies of Substrate Binding to Human Blood Group A and B Glycosyltransferases , 2017, Chembiochem : a European journal of chemical biology.

[7]  AB0 blood group and prognosis in patients with pancreatic cancer , 2012, BMC Cancer.

[8]  M. Palcic,et al.  A glycosyltransferase inhibitor from a molecular fragment library simultaneously interferes with metal ion and substrate binding. , 2012, Angewandte Chemie.

[9]  L. Tedaldi,et al.  Beyond substrate analogues: new inhibitor chemotypes for glycosyltransferases , 2014 .

[10]  M. Palcic,et al.  Thermodynamic signature of substrates and substrate analogs binding to human blood group B galactosyltransferase from isothermal titration calorimetry experiments. , 2013, Biopolymers.

[11]  M. Palcic,et al.  ABO(H) Blood Group A and B Glycosyltransferases Recognize Substrate via Specific Conformational Changes* , 2008, Journal of Biological Chemistry.

[12]  M. Palcic,et al.  Binding of an acceptor substrate analog enhances the enzymatic activity of human blood group B galactosyltransferase. , 2010, Glycobiology.

[13]  Bernd Meyer,et al.  Characterization of Ligand Binding by Saturation Transfer Difference NMR Spectroscopy. , 1999, Angewandte Chemie.

[14]  B. Meyer,et al.  Charakterisierung von Ligandenbindung durch Sättigungstransfer‐Differenz‐NMR‐Spektroskopie , 1999 .

[15]  Chem. , 2020, Catalysis from A to Z.

[16]  R. Duggleby,et al.  Parameter estimation using a direct solution of the integrated Michaelis-Menten equation. , 1999, Biochimica et biophysica acta.

[17]  Monica M. Palcic,et al.  The structural basis for specificity in human ABO(H) blood group biosynthesis , 2002, Nature Structural Biology.

[18]  B. Meyer,et al.  A nonionic inhibitor with high specificity for the UDP-Gal donor binding site of human blood group B galactosyltransferase: design, synthesis, and characterization. , 2013, Journal of medicinal chemistry.

[19]  J. Goerdeler,et al.  Über 1.2.4-Thiodiazole, VIII. Synthese von 5-Chlor-1.2.4-Thiodiazolen aus Perchlormethylmercaptan und Amidinen , 1957 .

[20]  M. Dolenc,et al.  Solid-phase synthesis of amidines by the reduction of amidoximes , 2004 .

[21]  M. Palcic,et al.  Enzymatic synthesis of blood group A and B trisaccharide analogues. , 2000, Carbohydrate research.

[22]  M. Palcic,et al.  NMR-based exploration of the acceptor binding site of human blood group B galactosyltransferase with molecular fragments , 2010, Glycoconjugate Journal.

[23]  Y. Cheng,et al.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. , 1973, Biochemical pharmacology.

[24]  B. Meyer,et al.  NMR for direct determination of K(m) and V(max) of enzyme reactions based on the Lambert W function-analysis of progress curves. , 2012, Biochimica et biophysica acta.

[25]  B. Judkins,et al.  A versatile synthesis of amidines from nitriles via amidoximes , 1996 .

[26]  Udo E W Lange,et al.  A new mild method for the synthesis of amidines , 1999 .

[27]  M. Palcic,et al.  The use of hydrophobic synthetic glycosides as acceptors in glycosyltransferase assays , 1988, Glycoconjugate Journal.

[28]  R. Garigipati.  An efficient conversion of nitriles to amidines , 1990 .

[29]  T. Lowary,et al.  High Resolution Structures of the Human ABO(H) Blood Group Enzymes in Complex with Donor Analogs Reveal That the Enzymes Utilize Multiple Donor Conformations to Bind Substrates in a Stepwise Manner* , 2015, The Journal of Biological Chemistry.